Tweet Exactech (NASDAQ:EXAC) will be posting its Q315 quarterly earnings results on Tuesday, October 27th. Analysts expect Exactech to post earnings of $0.25 per share and revenue of $58.46 million fo...
Here are five takeaways: 1. Asia is expected to witness a rapid growth due to an increasing population, rising awareness of technologies and increasing per capita income of hospitals. 2. The slowdown...
Over the past several years I have been commenting about the incredible number of metal on metal hip implant replacement failures. The epidemic of premature metal on metal hip implant failure continue...
French orthopedic implant company Implanet said Wednesday it won expanded FDA 510(k) clearance for its Jazz spinal implant allowing it to be used with other posterior thoraco-lumbar fixation systems....
Here are five things to know: 1. The company will present its two new ViewSite TC model devices. 2. The devices were designed much smaller in size to adapt to surgeons needs to perform less invasive s...
Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan Clinical trials for CFDA regulatory approval in preparation HOLZGERLINGEN, German...
Nexxt Spine, LLC, a medical device company focused on designing, manufacturing and distributing innovative spinal solutions to meet the evolving needs of surgeons and health care institutions, today a...
Arsenal CBx™ to Enter Full Commercial Launch by Year-end Featured at NASS Booth #1147 CARLSBAD, Calif., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC ), the parent company o...
Tweet Zacks upgraded shares of Exactech (NASDAQ:EXAC) from a sell rating to a hold rating in a research note released on Monday morning, Market Beat Ratings reports. According to Zacks, “Exactech, Inc...
LONDON, Sept. 17, 2015 /PRNewswire/ -- The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Spo...
